Open AccessClinical value of propranolol combined with oxaliplatin and tigio in concurrent chemoradiotherapy for locally advanced gastric cancer
Author(s) -
Yong Chen,
Yu Chen,
Zhibang Wang,
He Li,
Yongqi Wang
Publication year - 2022
Publication title -
pakistan journal of medical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.316
H-Index - 30
eISSN - 1682-024X
pISSN - 1681-715X
DOI - 10.12669/pjms.38.5.5311
Subject(s) - medicine , oxaliplatin , mucositis , adverse effect , bone marrow suppression , incidence (geometry) , gastroenterology , group b , capecitabine , sensitization , cancer , chemoradiotherapy , group a , radiation therapy , oncology , chemotherapy , colorectal cancer , immunology , physics , optics
To investigate the clinical value of propranolol combined with oxaliplatin and tigio in concurrent chemoradiotherapy for locally advanced gastric cancer.